Skip to main content
Top
Published in: Journal of Neurology 6/2015

Open Access 01-06-2015 | Original Communication

Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm

Authors: Marwa Elamin, Peter Bede, Anna Montuschi, Niall Pender, Adriano Chio, Orla Hardiman

Published in: Journal of Neurology | Issue 6/2015

Login to get access

Abstract

The objective of the study was to develop and validate a practical prognostic index for patients with amyotrophic lateral scleroses (ALS) using information available at the first clinical consultation. We interrogated datasets generated from two population-based projects (based in the Republic of Ireland and Italy). The Irish patient cohort was divided into Training and Test sub-cohorts. Kaplan–Meier methods and Cox proportional hazards regression were used to identify significant predictors of prognoses in the Training set. Using a weighted grading system, a prognostic index was derived that separated three risk groups. The validity of index was tested in the Irish Test sub-cohort and externally confirmed in the Italian replication cohort. In the Training sub-cohort (n = 117), significant predictors of prognoses were site of disease onset (HR = 1.7, p = 0.012); ALSFRS-R slope prior to first evaluation (HR = 2.8, p < 0.0001), and executive dysfunction (HR = 2.11, p = 0.001). The risk group system generated using these results predicted median survival time in the Training set, the Test set (n = 87) and the Italian cohort (n = 122) with no overlap of the 95 % CI (p < 0.0001). In the validation cohorts, a high-risk classification was associated with a positive predictive value for poor prognosis of 73.3–85.7 % and a negative predictive value (NPV) for good prognosis of 93.3–100 %. Classification into the low-risk group was associated with an NPV for bad prognosis of 100 %. A simple algorithm using variables that can be gathered at first patient encounter, validated in an independent patient series, reliably predicts prognoses in ALS patients.
Literature
1.
go back to reference Czaplinski A, Yen AA, Appel SH (2006) Amyotrophic lateral sclerosis: early predictors of prolonged survival. J Neurol 253:1428–1436CrossRefPubMed Czaplinski A, Yen AA, Appel SH (2006) Amyotrophic lateral sclerosis: early predictors of prolonged survival. J Neurol 253:1428–1436CrossRefPubMed
2.
go back to reference Beghi E, Mennini T, Bendotti C et al (2007) The heterogeneity of amyotrophic lateral sclerosis: a possible explanation of treatment failure. Curr Med Chem 14:3185–3200CrossRefPubMed Beghi E, Mennini T, Bendotti C et al (2007) The heterogeneity of amyotrophic lateral sclerosis: a possible explanation of treatment failure. Curr Med Chem 14:3185–3200CrossRefPubMed
4.
go back to reference Chio A, Ilardi A, Cammarosano S, Moglia C, Montuschi A, Calvo A (2012) Neurobehavioral dysfunction in ALS has a negative effect on outcome and use of PEG and NIV. Neurology 78:1085–1089CrossRefPubMed Chio A, Ilardi A, Cammarosano S, Moglia C, Montuschi A, Calvo A (2012) Neurobehavioral dysfunction in ALS has a negative effect on outcome and use of PEG and NIV. Neurology 78:1085–1089CrossRefPubMed
5.
go back to reference Elamin M, Phukan J, Bede P et al (2011) Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology 76:1263–1269CrossRefPubMed Elamin M, Phukan J, Bede P et al (2011) Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology 76:1263–1269CrossRefPubMed
6.
go back to reference Phukan J, Elamin M, Bede P et al (2012) The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 83:102–108CrossRefPubMed Phukan J, Elamin M, Bede P et al (2012) The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 83:102–108CrossRefPubMed
7.
go back to reference Elamin M, Bede P, Byrne S et al (2013) Cognitive changes predict functional decline in ALS: a population-based longitudinal study. Neurology 80:1590–1597CrossRefPubMed Elamin M, Bede P, Byrne S et al (2013) Cognitive changes predict functional decline in ALS: a population-based longitudinal study. Neurology 80:1590–1597CrossRefPubMed
8.
go back to reference O’Toole O, Traynor BJ, Brennan P et al (2008) Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry 79:30–32CrossRefPubMed O’Toole O, Traynor BJ, Brennan P et al (2008) Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry 79:30–32CrossRefPubMed
9.
go back to reference Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293–299CrossRefPubMed Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293–299CrossRefPubMed
10.
go back to reference Montuschi A, Iazzolino B, Calvo A et al (2015) Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry 86:168–173CrossRefPubMed Montuschi A, Iazzolino B, Calvo A et al (2015) Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry 86:168–173CrossRefPubMed
11.
go back to reference Chio A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R (2009) Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology 72:725–731CrossRefPubMed Chio A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R (2009) Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology 72:725–731CrossRefPubMed
12.
go back to reference Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169:13–21CrossRefPubMed Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169:13–21CrossRefPubMed
13.
go back to reference Kimura F, Fujimura C, Ishida S et al (2006) Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 66:265–267CrossRefPubMed Kimura F, Fujimura C, Ishida S et al (2006) Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 66:265–267CrossRefPubMed
14.
go back to reference Trenerry MCB, DeBoe J, Leber, W (1989) Stroop neuropsychological screening test manual: psychological assessment resources, Odessa, FL Trenerry MCB, DeBoe J, Leber, W (1989) Stroop neuropsychological screening test manual: psychological assessment resources, Odessa, FL
15.
go back to reference Abrahams S, Goldstein LH, Lloyd CM, Brooks DJ, Leigh PN (1995) Cognitive deficits in non-demented amyotrophic lateral sclerosis patients: a neuropsychological investigation. J Neurol Sci 129(Suppl):54–55CrossRefPubMed Abrahams S, Goldstein LH, Lloyd CM, Brooks DJ, Leigh PN (1995) Cognitive deficits in non-demented amyotrophic lateral sclerosis patients: a neuropsychological investigation. J Neurol Sci 129(Suppl):54–55CrossRefPubMed
16.
go back to reference Byrne S, Elamin M, Bede P et al (2012) Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol 11:232–240PubMedCentralCrossRefPubMed Byrne S, Elamin M, Bede P et al (2012) Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol 11:232–240PubMedCentralCrossRefPubMed
17.
go back to reference Kenna KP, McLaughlin RL, Byrne S et al (2013) Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing. J Med Genet 50:776–783PubMedCentralCrossRefPubMed Kenna KP, McLaughlin RL, Byrne S et al (2013) Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing. J Med Genet 50:776–783PubMedCentralCrossRefPubMed
18.
go back to reference Beghi E, Chio A, Couratier P et al (2011) The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials. Amyotroph Lateral Scler 12:1–10PubMedCentralCrossRefPubMed Beghi E, Chio A, Couratier P et al (2011) The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials. Amyotroph Lateral Scler 12:1–10PubMedCentralCrossRefPubMed
19.
go back to reference Bede P, Oliver D, Stodart J et al (2011) Palliative care in amyotrophic lateral sclerosis: a review of current international guidelines and initiatives. J Neurol Neurosurg Psychiatry 82:413–418CrossRefPubMed Bede P, Oliver D, Stodart J et al (2011) Palliative care in amyotrophic lateral sclerosis: a review of current international guidelines and initiatives. J Neurol Neurosurg Psychiatry 82:413–418CrossRefPubMed
20.
go back to reference Turner MR, Bakker M, Sham P, Shaw CE, Leigh PN, Al-Chalabi A (2002) Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 3:15–21CrossRefPubMed Turner MR, Bakker M, Sham P, Shaw CE, Leigh PN, Al-Chalabi A (2002) Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 3:15–21CrossRefPubMed
21.
go back to reference Scotton WJ, Scott KM, Moore DH et al (2012) Prognostic categories for amyotrophic lateral sclerosis. Amyotroph Lateral Scler 13:502–508CrossRefPubMed Scotton WJ, Scott KM, Moore DH et al (2012) Prognostic categories for amyotrophic lateral sclerosis. Amyotroph Lateral Scler 13:502–508CrossRefPubMed
22.
go back to reference Gargiulo-Monachelli GM, Janota F, Bettini M, Shoesmith CL, Strong MJ, Sica RE (2012) Regional spread pattern predicts survival in patients with sporadic amyotrophic lateral sclerosis. Eur J Neurol 19:834–841CrossRefPubMed Gargiulo-Monachelli GM, Janota F, Bettini M, Shoesmith CL, Strong MJ, Sica RE (2012) Regional spread pattern predicts survival in patients with sporadic amyotrophic lateral sclerosis. Eur J Neurol 19:834–841CrossRefPubMed
23.
go back to reference Paillisse C, Lacomblez L, Dib M, Bensimon G, Garcia-Acosta S, Meininger V (2005) Prognostic factors for survival in amyotrophic lateral sclerosis patients treated with riluzole. Amyotroph Lateral Scler Other Motor Neuron Disord 6:37–44CrossRefPubMed Paillisse C, Lacomblez L, Dib M, Bensimon G, Garcia-Acosta S, Meininger V (2005) Prognostic factors for survival in amyotrophic lateral sclerosis patients treated with riluzole. Amyotroph Lateral Scler Other Motor Neuron Disord 6:37–44CrossRefPubMed
24.
go back to reference Magnus T, Beck M, Giess R, Puls I, Naumann M, Toyka KV (2002) Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve 25:709–714CrossRefPubMed Magnus T, Beck M, Giess R, Puls I, Naumann M, Toyka KV (2002) Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve 25:709–714CrossRefPubMed
25.
go back to reference Czaplinski A, Yen AA, Simpson EP, Appel SH (2006) Predictability of disease progression in amyotrophic lateral sclerosis. Muscle Nerve 34:702–708CrossRefPubMed Czaplinski A, Yen AA, Simpson EP, Appel SH (2006) Predictability of disease progression in amyotrophic lateral sclerosis. Muscle Nerve 34:702–708CrossRefPubMed
26.
go back to reference del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G (2003) Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 60:813–819CrossRefPubMed del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G (2003) Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 60:813–819CrossRefPubMed
27.
28.
go back to reference Abrahams S, Newton J, Niven E, Foley J, Bak TH (2014) Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener 15:9–14CrossRefPubMed Abrahams S, Newton J, Niven E, Foley J, Bak TH (2014) Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener 15:9–14CrossRefPubMed
29.
go back to reference Woolley SC, York MK, Moore DH et al (2010) Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS). Amyotroph Lateral Scler 11:303–311CrossRefPubMed Woolley SC, York MK, Moore DH et al (2010) Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS). Amyotroph Lateral Scler 11:303–311CrossRefPubMed
30.
go back to reference Chio A, Mora G, Leone M et al (2002) Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology 59:99–103CrossRefPubMed Chio A, Mora G, Leone M et al (2002) Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology 59:99–103CrossRefPubMed
31.
go back to reference Testa D, Lovati R, Ferrarini M, Salmoiraghi F, Filippini G (2004) Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period. Amyotroph Lateral Scler Other Motor Neuron Disord 5:208–212PubMed Testa D, Lovati R, Ferrarini M, Salmoiraghi F, Filippini G (2004) Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period. Amyotroph Lateral Scler Other Motor Neuron Disord 5:208–212PubMed
32.
go back to reference Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O (2003) An outcome study of riluzole in amyotrophic lateral sclerosis—a population-based study in Ireland, 1996-2000. J Neurol 250:473–479CrossRefPubMed Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O (2003) An outcome study of riluzole in amyotrophic lateral sclerosis—a population-based study in Ireland, 1996-2000. J Neurol 250:473–479CrossRefPubMed
33.
go back to reference Sutedja NA, Veldink JH, Fischer K et al (2007) Lifetime occupation, education, smoking, and risk of ALS. Neurology 69:1508–1514CrossRefPubMed Sutedja NA, Veldink JH, Fischer K et al (2007) Lifetime occupation, education, smoking, and risk of ALS. Neurology 69:1508–1514CrossRefPubMed
34.
go back to reference Lopez-Vega JM, Calleja J, Combarros O, Polo JM, Berciano J (1988) Motor neuron disease in Cantabria. Acta Neurol Scand 77:1–5CrossRefPubMed Lopez-Vega JM, Calleja J, Combarros O, Polo JM, Berciano J (1988) Motor neuron disease in Cantabria. Acta Neurol Scand 77:1–5CrossRefPubMed
35.
go back to reference Marti-Fabregas J, Pradas J, Illa I (1996) Prognostic factors in amyotrophic lateral sclerosis. Neurologia 11:174–181PubMed Marti-Fabregas J, Pradas J, Illa I (1996) Prognostic factors in amyotrophic lateral sclerosis. Neurologia 11:174–181PubMed
36.
go back to reference Chancellor AM, Slattery JM, Fraser H, Swingler RJ, Holloway SM, Warlow CP (1993) The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register. J Neurol 240:339–346CrossRefPubMed Chancellor AM, Slattery JM, Fraser H, Swingler RJ, Holloway SM, Warlow CP (1993) The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register. J Neurol 240:339–346CrossRefPubMed
Metadata
Title
Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm
Authors
Marwa Elamin
Peter Bede
Anna Montuschi
Niall Pender
Adriano Chio
Orla Hardiman
Publication date
01-06-2015
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 6/2015
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-015-7731-6

Other articles of this Issue 6/2015

Journal of Neurology 6/2015 Go to the issue